The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPET.L Regulatory News (BPET)

  • There is currently no data for BPET

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

28 Aug 2015 07:00

RNS Number : 3564X
F&C Private Equity Trust PLC
28 August 2015
 



To: Stock Exchange

For immediate release:

28 August 2015

 

F&C Private Equity Trust plc

 

Unaudited results for the half year to 30 June 2015

 

 

 

Financial Highlights

 

· NAV total return for the six months of 2.7 per cent.

 

· Share price total return for the six months of 1.6 per cent.

 

· Semi-annual dividend of 5.58p per Ordinary Share.

 

· Annualised dividend yield of 5.2 per cent at the period end.

 

 

Chairman's Statement

 

As at 30 June 2015 the Company's net asset value ('NAV') was £205.1 million giving a fully diluted NAV per share of 279.69p. Taking into account last year's final dividend of 5.45p per share paid on 29 May 2015 the NAV total return for the first half of the year was 2.7 per cent. At the end of the period the Company had cash of £18.6 million. Together with borrowings of £34.6 million under the Company's loan facility, net debt was £16.0 million, equivalent to a gearing level of 7.2 per cent. The total of outstanding undrawn commitments at 30 June was £64.7 million and, of this, approximately £18 million is to funds where the investment period has expired.

 

Currency movements were an adverse factor during the period, with sterling strengthening against all the major currencies. This was partially offset by the Company's borrowings being in Euros, but the net impact for the period was approximately 2.3 per cent of the NAV per share.

 

In accordance with the Company's stated dividend policy, the Board declares a semi-annual dividend of 5.58p per ordinary share, payable on 6 November 2015 to shareholders on the register on 9 October 2015. For illustrative purposes only, this dividend represents an annualised yield of 5.2 per cent based on the share price as at 30 June 2015. I would like to remind shareholders of our dividend reinvestment plan which can be a convenient and easy way to build up an existing holding.

 

The first half of the year has seen a continuation of the strong exit environment that featured last year. Indeed the total of realisations for the Company in the first half, at £35.7 million, is approximately 70 per cent above the total at the same point last year. These realisations have come from every part of the portfolio; funds, co-investments, secondaries and covering all geographies and sectors. In general these have been at very acceptable prices and the decisions to continue investing taken by our investment partners through the recession are bearing, and should continue to bear, fruit.

 

Much of this activity is connected to improved levels of business and investor confidence and with this comes improvement in prices. From a buyer's perspective this can pose a challenge. Pricing across the private equity market has increased considerably in the last two years or so and this is apparent even in the European lower mid-market where the great majority of our investment activity is focused. Apart from confidence it reflects a banking and 'non-banking' sector with good liquidity and an appetite to lend as well as substantial fund raising by private equity funds across the market. Each of these factors acts to push up prices, especially for companies with uncomplicated growth 'stories' where competition to acquire them can be intense. Our investment partners have not been conspicuous in paying high prices and are much more likely to be frustrated in highly competitive auctions than to secure the deal at an uncomfortably high price where there is little room for any subsequent underperformance in the investee company without painful consequences. This is because of their adherence to an agreed investment policy and required return commensurate with the relatively high risks involved in private equity investment.

Despite this environment, it remains the case that in the broad and inefficient regional lower mid-market of Europe, skilled and well-connected private equity investors can find and acquire companies at reasonable prices. The Company's current and future performance is entirely dependent on your Managers successfully investing through and alongside such investment partners. Their dealflow of funds, co-investments and secondaries provides plenty of evidence that this is happening.

 

At the Annual General Meeting in May shareholders approved our proposal to increase the limit for co-investments from 33 per cent of the Company's total assets at the time of investment to 50 per cent, with a limit of 5 per cent for any individual direct co-investment. The current exposure to co-investments stands at 22.5 per cent and we expect that this will increase steadily to over 30 per cent over the short to medium term. Your Managers have access to excellent dealflow in co-investments and have successfully completed dozens of these investments during the Company's life, providing a strong contribution to performance. Apart from the direct impact on the performance of successfully realised co-investments, the insight which your Managers receive into the valuation creation process at a range of private equity firms delivers an indirect benefit by improving their selection of managers and funds.

 

 

Mark Tennant

Chairman

 

 

 

 

Manager's Review

 

Introduction

As noted in the Chairman's Statement, a striking feature of the first half of the year has been the strong exit environment which has resulted in £35.7 million of realisations from the portfolio. In every reporting period we expect the Company to have a healthy total of realisations because it has a portfolio that is well diversified by the age of investments and there are always some investments coming to maturity. The volume of exits relative to the size of the portfolio fluctuates with the overall market and, in particular, with the appetite of trade buyers to make deals and of larger private equity firms to deploy equity capital. The provision of bank finance or non-bank debt also has a big influence on buy-out activity which remains the dominant mode of private equity investment. All of these factors are acting to increase realisations at present. Despite a recurrence of Eurozone worries during the period there remains a high level of confidence in the economic future of Europe and also in the uniquely effective model of investment provided by private equity.

 

New Investments

The total amount invested through drawdowns by funds and co-investments during the first half of the year was £19.2 million.

 

Three fund commitments were made. €5 million was committed to Corpfin IV. This is managed by one of the leading Iberian mid-market specialists and it is well placed to find good opportunities in the recovering economies of Spain and Portugal. €4 million was committed to the Milan based Italian mid-market specialist Aliante 3. The portfolio in this fund has been building up for three years already and this gives us immediate visibility. Aliante has a focus on the food and beverage sector where Italy offers some excellent investment opportunities. Finally, £4.8 million was committed to UK mid-market fund RJD Partners III, one of our longstanding investment partners.

 

Two new co-investments have been added to the portfolio. £4.5 million was invested in Burgess Marine. This was syndicated down to a hold position of £3.0 million giving a 19 per cent holding for the Company in this Dover based marine engineering services company. This deal was led by RJD Partners, with whom we have made several co-investments over the years, and it gives us exposure to three growing businesses within Burgess Marine: refitting of commercial and naval vessels; boat building for shallow draft workboats and wind farm support vessels; and refitting superyachts. £1.3 million was invested in superfoods company, Nutrisure, for a 13 per cent stake. This deal was led by Lonsdale, with whom we have previously co-invested. Nutrisure is a direct play on the very strong growth in demand for superfoods, which are defined as foods that are high in antioxidants, phytonutrients, vitamins, minerals, enzymes and amino acids. Trading under the brand Naturya, the company is growing rapidly and Lonsdale has acquired it at a compelling price.

 

Drawdowns by the funds in the portfolio have been typically varied.

 

In the UK, one of our key investment partners, Inflexion, has been particularly active. £1.4 million was called by its 2010 Fund and 2012 Co-investment Fund for investment in luxury travel agency Scott Dunn. The premium end of the holiday market is growing strongly. Inflexion also invested for us through its 2012 Co-investment Fund with £1.5 million in Shimtech, a global market leader in the manufacture of specialist gap management components, or 'shims', which are essential in the assembly of commercial aircraft.

 

In Germany, DBAG VI made two major investments. £0.4 million was called for Gienanth, an iron foundry company specialising in casting engine blocks for large diesel and gas engines. Another £0.4 million was called for Cleanpart, a provider of engineering services to the semi-conductor industry. This is a relatively high tech development of DBAG's preferred investment focus on the 'factories of the factories' of Germany.

 

Realisations

The Company is in the midst of a strong run of realisations. These are remarkably broadly spread by sector and geography.

 

The largest realisation, of £8.6 million, was the sale of the co-investment in SMD Hydrovision, to Chinese buyer ZhouZou CSR. This seven year hold achieved 2.1x cost and an IRR of 11 per cent. Inflexion, the deal leaders, had worked closely with the company to improve its market position and hence its strategic value, and this compensated for relatively volatile profits over the holding period. Another longstanding co-investment, Whittan, the Stirling Square lead pallet racking systems provider, was sold to European private equity house Bregal, returning £2.7 million, which covered the cost of the investment. With an economically sensitive customer base the company had faced challenges in the recession but had recovered with help from an equity refinancing which acted to protect the investment.

 

Several other UK based companies held within the funds have been sold with excellent returns. Piper Private Equity IV sold Rollover Holdings, the UK's leading food service hotdog company, to Kerry Group plc, achieving a 2.5x multiple with proceeds of £0.8 million. Inflexion, as already noted, has been very active. Aspen Pumps was sold by its 2006 Fund, returning £0.7 million, which represents 14x cost and an IRR of 40 per cent. Inflexion also exited for its 2010 Fund and 2012 Co-investment Fund, two companies; Sanne and CTC Aviation. Sanne, a trust fund and fund administration services business based in Jersey, was listed on the London Stock Exchange, allowing Inflexion to exit 75 per cent of its holding. Including the value of the remaining holding, the money multiple and IRR was 3.7x and 80 per cent respectively. CTC Aviation is an integrated pilot training service provider which has grown successfully, capitalising on the worldwide shortage of pilots. The company opened a new training base in the US to complement its existing facilities in the UK and New Zealand. CTC was sold to L-3, an aerospace systems and national security solutions contractor, achieving a multiple of 3.0x cost and an IRR of 46 per cent. Since the end of the period, Inflexion has achieved three further realisations of Consumer Champion (formerly National Accident Helpline), the personal injury claims specialist, with a multiple of 3.8x and an IRR of 36 per cent, Rhead Group, the international professional services consultancy, for 1.8x and a 17 per cent IRR and Reward Gateway, the SaaS employee engagement specialist, for 7.7x and a 59 per cent IRR.

 

In Continental Europe, there was also a range of exits. The Company's only Life Science venture capital fund, the Netherlands based Life Science Partners III, distributed £1.7 million, as the proceeds of the sale of Prosensa, the pharmaceutical company specialising in RNA modulating therapeutics with potentially ground breaking applications in certain genetic diseases. In Poland, Accession Mezzanine II returned £0.7 million from the sale of metallic enhancement company Norican to Nordic private equity house Altor, achieving just above cost.

 

In Germany, Capvis III sold Wittur (elevator components) to Bain Capital returning £1.2 million for 3.9x cost and an IRR of 38 per cent. In the Benelux, Gilde Buyout III has had two realisations. Bekaert Textiles, a manufacturer of woven and knitted fabrics for mattresses and bed coverings, was sold returning £0.9 million, 6.5x cost and a 49 per cent IRR. Plukon Royale, a poultry meat processor, was sold, returning £1.2 million, 7.8x cost and a 41 per cent IRR. In France, Chequers Capital XV sold Serma, a designer of embedded electronic systems used in severe environments, to French PE house Ardian, returning £0.5 million, 3.1x cost and a 34 per cent IRR.

 

In the US, Blue Point Capital II achieved an excellent exit with the sale of Area Wide Protective (AWP), the provider of outsourced work zone safety services to utilities, which was sold to Riverside, achieving a multiple of 11x, an IRR of 51 per cent and proceeds to the Company of £2.9 million.

 

Valuation Changes

The uplifts in the portfolio were fairly broadly spread. The Spanish fund N+1 Private Equity II was up by £1.7 million reflecting several uplifts across the portfolio. Blue Point Capital II was up by £1.7 million mainly reflecting the sale of AWP noted above. Pentech II, the Edinburgh based venture capital fund, was up by £1.1 million as a result of a major uplift in the value of FanDuel, the global leader in one day fantasy sports, which has just successfully raised $275 million and now has a valuation in excess of $1 billion. The two main Inflexion funds, the 2010 Fund and the 2012 Co-investment Fund, were up by £1.2 million and £1.1 million respectively, reflecting the successful exits of Sanne Group and CTC Aviation. The FSN led Danish co-investment in housebuilder HusCompagniet was sold to Nordic Private Equity fund EQT after the end of the period and this resulted in an uplift in this valuation of £1.1 million. The outcome is likely to be an investment multiple of 3.8x cost with a 46 per cent IRR and the Company's valuation is just below this. Also in the Nordic region, the Agilitas co-investment in Recover Nordic, the damage control business, was uplifted by £1.0 million to reflect the company's progress.

 

There have been some downgrades. Herkules Private Equity III, which is heavily exposed to the oil related economy of Norway, was down by £0.7 million following a number of downward adjustments across the portfolio. Piper Private Equity IV was down by £0.3 million mainly because of downgrades in the value of Diet Chef and clothes retailer Weird Fish.

 

Currency has again been an adverse factor with sterling strengthening against all the principal currencies over the first half of the year. There was a partial offsetting of this through the Company's borrowings being in Euros, but the net impact was approximately 2.3 per cent for the six month period.

 

Financing

The Company's balance sheet has strengthened over the six month period with a healthy excess of realisations over drawdowns, leading to a significant reduction in net debt. Debt will rise again as pending new investments are made. The Company has considerable capacity to take advantage of both fund and co-investment opportunities and to buy selected secondaries. It is likely that the proportion of co-investments will increase steadily in the future and also that the outstanding undrawn commitments will increase from the current level which is close to the historical low. The Company will progressively benefit from the much lower cost of borrowing under the Royal Bank of Scotland loan facility compared with the previously held zero dividend preference shares.

 

Outlook

The surge in exits that began last year has continued strongly into the first half of 2015. Current activity levels indicate that this is being maintained. Fund raising for private equity funds has, if anything, strengthened further this year with a number of funds reportedly being 'over subscribed'. The banking and 'shadow banking' sectors have good liquidity and this is facilitating increasingly leveraged deal structures. Pricing of new deals has gone up and although anecdotal evidence suggests that in some instances pricing is unreasonably high, the deals we have seen executed by our investment partners do not indicate that they are chronically over-paying. The co-investment deal flow, which tends to be at the smaller end of the mid-market, is generally at attractive prices. The pricing situation needs careful surveillance and monitoring current and future funds for adherence to pricing disciplines is important. The macro-economic background in the Eurozone remains dominated by the periodic Greek crises which are not helpful for business and consumer confidence across Europe as a whole, but they do not seem to have adversely affected deal making activity within the private equity market. There are good grounds for expecting further respectable appreciation in the value of the portfolio during the remainder of the year and beyond.

 

 

Hamish Mair

Investment Manager

F&C Investment Business Limited

 

 

 

F&C Private Equity Trust plc

 

Statement of Comprehensive Income for the

half year ended 30 June 2015

 

Unaudited

 

Revenue

£'000

Capital

£'000

Total

£'000

Income

Gains on investments held at fair value

-

1,176

1,176

Exchange gains

-

3,266

3,266

Investment income

4,307

-

4,307

Other income

16

-

16

Total income

4,323

4,442

8,765

Expenditure

Investment management fee - basic fee

(247)

(742)

(989)

Investment management fee - performance fee

-

(973)

(973)

Other expenses

(340)

-

(340)

Total expenditure

(587)

(1,715)

(2,302)

Profit before finance costs and taxation

3,736

2,727

6,463

Finance costs

(232)

(697)

(929)

Profit before taxation

3,504

2,030

5,534

Taxation

(708)

708

-

Profit for period/total comprehensive income

2,796

2,738

5,534

Return per Ordinary Share - Basic

3.87p

3.79p

7.66p

Return per Ordinary Share - Fully diluted

3.77p

3.68p

7.45p

 

The total column of this statement represents the Statement of Comprehensive Income of the Company, prepared in accordance with IFRS. The supplementary revenue and capital columns are both prepared under guidance published by the Association of Investment Companies.

 

All revenue and capital items in the above statement derive from continuing operations.

 

All income is attributable to the equity holders of F&C Private Equity Trust plc. There are no minority interests.

F&C Private Equity Trust plc

 

Statement of Comprehensive Income for the

half year ended 30 June 2014

 

Unaudited

 

Revenue

£'000

Capital

£'000

Total

£'000

Income

Gains on investments held at fair value

-

992

992

Exchange gains

-

128

128

Investment income

2,220

-

2,220

Other income

11

-

11

Total income

2,231

1,120

3,351

Expenditure

Investment management fee - basic fee

(258)

(774)

(1,032)

Investment management fee - performance fee

-

-

-

Other expenses

(301)

-

(301)

Total expenditure

(559)

(774)

(1,333)

Profit before finance costs and taxation

1,672

346

2,018

Finance costs

(196)

(2,533)

(2,729)

Profit/(loss) before taxation

1,476

(2,187)

(711)

Taxation

(318)

318

-

Profit/(loss) for period/total comprehensive income

1,158

(1,869)

(711)

Return/(loss) per Ordinary Share - Basic

1.60p

(2.58)p

(0.98)p

Return/(loss) per Ordinary Share - Fully diluted

1.56p

(2.52)p

(0.96)p

 

The total column of this statement represents the Statement of Comprehensive Income of the Company, prepared in accordance with IFRS. The supplementary revenue and capital columns are both prepared under guidance published by the Association of Investment Companies.

 

All revenue and capital items in the above statement derive from continuing operations.

 

All income is attributable to the equity holders of F&C Private Equity Trust plc. There are no minority interests.

F&C Private Equity Trust plc

 

Statement of Comprehensive Income for the

year ended 31 December 2014

 

Audited

 

Revenue

£'000

Capital

£'000

Total

£'000

Income

Gains on investments held at fair value

-

18,588

18,588

Exchange gains

-

572

572

Investment income

3,971

-

3,971

Other income

27

-

27

Total income

3,998

19,160

23,158

Expenditure

Investment management fee - basic fee

(516)

(1,548)

(2,064)

Investment management fee - performance fee

-

(1,085)

(1,085)

Other expenses

(745)

-

(745)

Total expenditure

(1,261)

(2,633)

(3,894)

Profit before finance costs and taxation

2,737

16,527

19,264

Finance costs

(349)

(4,854)

(5,203)

Profit before taxation

2,388

11,673

14,061

Taxation

(441)

441

-

Profit for year/total comprehensive income

1,947

12,114

14,061

Return per Ordinary Share - Basic

2.69p

16.76p

19.45p

Return per Ordinary Share - Fully diluted

2.62p

16.32p

18.94p

 

The total column of this statement represents the Statement of Comprehensive Income of the Company, prepared in accordance with IFRS. The supplementary revenue and capital columns are both prepared under guidance published by the Association of Investment Companies.

 

All revenue and capital items in the above statement derive from continuing operations.

 

All income is attributable to the equity holders of F&C Private Equity Trust plc. There are no minority interests.

 

F&C Private Equity Trust plc

 

Amounts Recognised as Dividends

 

 

 

 

Six months ended 30 June 2015 (unaudited)

£'000

Six months ended 30 June 2014 (unaudited)

£'000

 

Year ended 31 December 2014

(audited)

£'000

Final Ordinary Share dividend of 5.36p per share for the year ended 31 December 2013

-

3,874

3,874

Interim Ordinary Share dividend of 5.39p per share for the year ended 31 December 2014

-

-

3,896

Final Ordinary Share dividend of 5.45p per share for the year ended 31 December 2014

3,939

 

-

-

3,939

3,874

7,770

 

 

 

F&C Private Equity Trust plc

 

Balance Sheet

 

As at 30 June 2015

(unaudited)

As at 30 June 2014(unaudited)As at 31 December 2014

(audited)

£'000

£'000

 £'000

Non-current assets

Investments at fair value through profit or loss

223,378

233,673

234,414

Subsidiary undertaking

-

56

-

223,378

233,729

234,414

Current assets

Other receivables

32

36

2,577

Cash and short-term deposits

18,617

3,481

6,946

18,649

3,517

9,523

Current liabilities

Other payables

(16,533)

(835)

(18,117)

Amounts due to subsidiary

-

(43,779)

-

Net current assets/(liabilities)

2,116

(41,097)

(8,594)

Total assets less current liabilities

225,494

192,632

225,820

 Non-current liabilities

Interest-bearing bank loan

(20,391)

-

(22,312)

Net assets

205,103

192,632

203,508

Equity

Called-up ordinary share capital

723

723

723

Special distributable capital reserve

15,679

15,679

15,679

Special distributable revenue reserve

31,403

31,403

31,403

Capital redemption reserve

1,335

1,335

1,335

Capital reserve

148,568

139,682

149,769

Revenue reserve

7,395

3,810

4,599

Shareholders' funds

205,103

192,632

203,508

Net asset value per Ordinary Share - Basic

283.75p

266.50p

281.55p

Net asset value per Ordinary Share - Fully diluted

 

279.69p

 

262.90p

 

277.55p

 

F&C Private Equity Trust plc

Statement of Changes in Equity

 

 

 

 

 

Share Capital

Special Distributable Capital Reserve

Special Distributable Revenue Reserve

 

Capital Redemption Reserve

 

 

Capital Reserve

 

 

Revenue Reserve

 

 

 

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

For the six months ended 30 June 2015 (unaudited)

 

 

 

 

 

 

 

 

Net assets at 1 January 2015

723

15,679

31,403

1,335

149,769

4,599

203,508

Profit for the period/total comprehensive income

-

-

-

-

2,738

2,796

5,534

Dividends paid

-

-

-

-

(3,939)

-

(3,939)

 

 

 

 

 

 

 

 

Net assets at 30 June 2015

723

15,679

31,403

1,335

148,568

7,395

205,103

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the six months ended 30 June 2014 (unaudited)

 

 

 

 

 

 

 

 

Net assets at 1 January 2014

723

15,679

31,403

1,335

145,425

2,652

197,217

(Loss)/profit for the period/total comprehensive income

-

-

-

-

(1,869)

1,158

(711)

Dividends paid

-

-

-

-

(3,874)

-

(3,874)

 

 

 

 

 

 

 

 

Net assets at 30 June 2014

723

15,679

31,403

1,335

139,682

3,810

192,632

 

 

For the year ended 31 December 2014 (audited)

 

 

 

 

 

 

 

 

Net assets at 1 January 2014

723

15,679

31,403

1,335

145,425

2,652

197,217

Profit for the year/total comprehensive income

-

-

-

-

12,114

1,947

14,061

Dividends paid

-

-

-

-

(7,770)

-

(7,770)

 

 

 

 

 

 

 

 

Net assets at 31 December 2014

723

15,679

31,403

1,335

149,769

4,599

203,508

 

 

 

 

 

 

 

 

F&C Private Equity Trust plc

 

Cash Flow Statement

 

 

Six months ended

30 June 2015

(unaudited)

Six months ended

30 June 2014

(unaudited)

Year ended

31 December 2014

(audited)

£000

£000

£000

Operating activities

Profit/(loss) before taxation

5,534

(711)

14,061

Gains on disposals of investments

(10,292)

(3,607)

(10,539)

Decrease/(increase) in holding gains

9,116

2,615

(8,049)

Exchange differences

(3,266)

(128)

(572)

Finance costs

929

2,729

5,203

Increase in other receivables

(4)

(9)

-

Decrease in other payables

(206)

(1,753)

(34)

 

Net cash inflow/(outflow) from operating activities

 

1,811

 

(864)

 

70

Investing activities

Purchases of investments

(19,177)

(13,785)

(29,114)

Sales of investments

33,938

18,714

48,404

 

Net cash inflow from investing activities

 

14,761

 

4,929

 

19,290

Financing activities

Repayment of bank loans

-

(7,286)

(7,286)

Draw down of bank loans

-

4,086

42,461

Amounts paid to subsidiary

-

-

(45,642)

Interest paid

(848)

(520)

(980)

Equity dividends paid

(3,939)

(3,874)

(7,770)

 

Net cash outflow from financing activities

(4,787)

(7,594)

 

(19,217)

 

Net increase/(decrease) in cash and cash equivalents

 

11,785

 

(3,529)

 

143

Currency (losses)/gains

(114)

1

(206)

 

Net increase/(decrease) in cash and cash equivalents

 

11,671

 

(3,528)

 

(63)

Opening cash and cash equivalents

6,946

7,009

7,009

 

Closing cash and cash equivalents

 

18,617

 

3,481

 

6,946

 

 

Statement of Principal Risks and Uncertainties

 

 

The Directors believe that the principal risks and uncertainties faced by the Company include investment and strategic, external, regulatory, operational, financial and funding. The Company is also exposed to risks in relation to its financial instruments. These risks, and the way in which they are managed, are described in more detail under the heading Principal Risks and Uncertainties and Risk Management within the Business Model and Strategy in the Annual Report for the year ended 31 December 2014. The Company's principal risks and uncertainties have not changed materially since the date of that report and are not expected to change materially for the remaining six months of the Company's financial year.

 

 

Statement of Directors' Responsibilities in Respect of the Half Year Report

 

We confirm that to the best of our knowledge:

 

· the condensed set of financial statements have been prepared in accordance with IAS 34 'Interim Financial Reporting' and give a true and fair view of the assets, liabilities, financial position and profit of the Company;

 

· the Chairman's Statement and Manager's Review (together constituting the Interim Management Report) include a fair review of the information required by the Disclosure and Transparency Rules ('DTR') 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the financial statements;

 

· the Statement of Principal Risks and Uncertainties shown above is a fair review of the information required by DTR 4.2.7R; and

 

· the condensed set of financial statements include a fair review of the information required by DTR 4.2.8R, being related party transactions that have taken place in the first six months of the financial year and that have materially affected the financial position or performance of the Company during the period, and any changes in the related party transactions described in the last Annual Report that could do so.

 

 

On behalf of the Board

 

 

Mark Tennant

Chairman

 

Notes (unaudited)

 

1. The condensed company financial statements have been prepared in accordance with International Financial Reporting Standard ('IFRS') IAS 34 'Interim Financial Reporting' and the accounting policies set out in the statutory accounts for the year ended 31 December 2014. The condensed financial statements do not include all of the information required for a complete set of IFRS financial statements and should be read in conjunction with the financial statements for the year ended 31 December 2014, which were prepared under full IFRS requirements.

 

2. Earnings for the six months to 30 June 2015 should not be taken as a guide to the results for the year to 31 December 2015.

 

3. Investment management fee:

 

 

 

Six months to

30 June 2015

 

 

Six months to

30 June 2014

 

 

Year ended

31 December 2014

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Investment management fee

247

742

989

258

774

1,032

516

1,548

2,064

Performance fee

-

973

973

-

-

-

-

1,085

1,085

 

 

 

 

 

 

 

 

 

 

 

247

1,715

1,962

258

774

1,032

516

2,633

3,149

 

 

 

 

 

 

 

 

 

 

 

4. Finance costs:

 

 

 

Six months to

30 June 2015

 

 

Six months to

30 June 2014

 

 

Year ended

31 December 2014

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Interest payable on bank loans and overdrafts

232

697

929

196

589

785

349

1,047

1,396

Finance costs attributable to subsidiary loan

-

-

-

-

1,944

1,944

-

3,807

3,807

 

 

 

 

 

 

 

 

 

 

 

232

697

929

196

2,533

2,729

349

4,854

5,203

 

 

 

 

 

 

 

 

 

 

 

5. The basic return per Ordinary Share is based on a net profit on ordinary activities after taxation of £5,534,000 (30 June 2014 - loss £711,000; 31 December 2014 - profit £14,061,000) and on 72,282,273 (30 June 2014 - 72,282,273; 31 December 2014 - 72,282,273) shares, being the weighted average number of Ordinary Shares in issue during the period.

 

The fully diluted return per Ordinary Share is based on a net profit on ordinary activities after taxation of £5,534,000 (30 June 2014 - loss £711,000; 31 December 2014 - profit £14,061,000) and on 74,241,429 (30 June 2014 - 74,241,429; 31 December 2014 - 74,241,429) shares, being the weighted average number of Ordinary Shares in issue during the period after conversion of the Ordinary Share warrants.

 

6. The basic net asset value per Ordinary Share is based on net assets at the period end of £205,103,000 (30 June 2014 - £192,632,000; 31 December 2014 - £203,508,000) and on 72,282,273 (30 June 2014 - 72,282,273; 31 December 2014 - 72,282,273) shares, being the number of Ordinary Shares in issue at the period end.

 

 

The fully diluted net asset value per Ordinary Share is based on net assets at the period end of £207,649,000 (30 June 2014 - £195,178,000; 31 December 2014 - £206,054,000) and on 74,241,429 (30 June 2014 - 74,241,429; 31 December 2014 - 74,241,429) shares, being the number of Ordinary Shares in issue at the period end after conversion of the Ordinary Share warrants.

 

Since the end of the period, the Company has bought back 300,000 Ordinary Shares for cancellation.

 

7. The fair value measurements for financial assets and liabilities are categorised into different levels in

the fair value hierarchy based on inputs to valuation techniques used. The different levels are defined as follows:

 

Level 1 reflects financial instruments quoted in an active market.

 

Level 2 reflects financial instruments whose fair value is evidenced by comparison with other observable current market transactions in the same instrument or based on a valuation technique whose variables includes only data from observable markets.

 

Level 3 reflects financial instruments whose fair value is determined in whole or in part using a valuation technique based on assumptions that are not supported by prices from observable market transactions in the same instrument and not based on available observable market data.

Level 1

Level 2

Level 3

Total

£'000

£'000

£'000

£'000

 

30 June 2015

Financial assets

Investments

406

-

222,972

223,378

30 June 2014

Financial assets

Investments

1,897

-

231,776

233,673

31 December 2014

Financial assets

Investments

560

-

233,854

234,414

There were no transfers between levels in the fair value hierarchy in the period ended 30 June 2015. Transfers between levels of the fair value hierarchy are deemed to have occurred at the date of the event that caused the transfer.

 

Valuation techniques

Quoted fixed asset investments held are valued at bid prices which equate to their fair values. Unlisted investments are fair valued by the Directors. The fair value of a holding is based on the Company's share of the total net asset value of the fund or share of the valuation of the co-investment calculated by the lead private equity manager on a quarterly basis. The lead private equity manager derives the net asset value of a fund from the fair value of underlying investments. The fair value of these underlying investments and the Company's co-investments is calculated using methodology which is consistent with the International Private Equity and Venture Capital Valuation Guidelines ('IPEG'). In accordance with IPEG these investments are generally valued using an appropriate multiple of maintainable earnings, which has been derived from comparable multiples of quoted companies or recent transactions. The F&C private equity team has access to the underlying valuations used by the lead private equity managers including multiples and any adjustments. The F&C private equity team generally values the Company's holdings in line with the lead managers but may make adjustments where they do not believe the underlying managers' valuations represent fair value. On a quarterly basis, the F&C private equity team present the valuations to the Board. This includes a discussion of the major assumptions used in the valuations, which focuses on significant investments and significant changes in the fair value of investments. If considered appropriate, the Board will approve the valuations. The fair values of all of the Company's other financial assets and liabilities are not materially different from their carrying values in the balance sheet.

 

Significant unobservable inputs for Level 3 valuations

The Company's unlisted investments are all classified as Level 3 investments. The fair values of the unlisted investments have been determined principally by reference to earnings multiples, with adjustments made as appropriate to reflect matters such as the sizes of the holdings and liquidity. The weighted average earnings multiple for the portfolio as at 30 June 2015 was 7.9 times EBITDA (Earnings Before Interest, Tax, Depreciation and Amortisation) (30 June 2014: 7.8 times EBITDA; 31 December 2014: 7.7 times EBITDA).

 

The significant unobservable input used in the fair value measurement categorised within Level 3 of the fair value hierarchy together with a quantitative sensitivity analysis are shown below:

 

Period ended

Input

Sensitivity used*

Effect on fair value £'000

30 June 2015

Weighted average earnings multiple

1x

39,816

30 June 2014

Weighted average earnings multiple

1x

44,572

31 December 2014

Weighted average earnings multiple

1x

44,972

* The sensitivity analysis refers to an amount added or deducted from the input and the effect this has on the fair value.

 

The fair value of the Company's unlisted investments are sensitive to changes in the assumed earnings multiples. The managers of the underlying funds assume an earnings multiple for each holding. An increase in the weighted average earnings multiple would lead to an increase in the fair value of the investment portfolio and a decrease in the multiple would lead to a decrease in the fair value.

 

The following table shows a reconciliation of all movements in the fair value of financial instruments categorised within Level 3 between the beginning and the end of the period:

 

30 June 2015

30 June 2014

31 December 2014

£'000

£'000

£'000

Balance at beginning of period

233,854

236,308

236,308

Purchases

19,177

13,785

29,114

Sales

(31,383)

(18,714)

(49,826)

Gains on disposal

10,285

3,999

10,909

In specie distribution

(23)

(165)

(165)

(Decrease)/increase in holding gains

(8,938)

(3,437)

7,514

Balance at end of period

222,972

231,776

233,854

 

8. In assessing the going concern basis of accounting the Directors have had regard to the guidance issued by the Financial Reporting Council. They have considered the current cash position of the Company, the availability of the Company's loan facility and compliance with its covenants. They have also considered forecast cash flows, especially those relating to capital commitments and realisations.

 

As at 30 June 2015, the Company had outstanding undrawn commitments of £64.7 million. Of this amount, approximately £18 million is to funds where the investment period has expired and the Manager would expect very little of this to be drawn. Of the outstanding undrawn commitments remaining within their investment periods, the Manager would expect that a significant amount will not be drawn before these periods expire.

 

Based on this information the Directors believe the Company has the ability to meet its financial obligations as they fall due for a period of at least twelve months from the date of approval of the accounts. Accordingly, the accounts have been prepared on a going concern basis.

 

 

9. These are not statutory accounts in terms of Section 434 of the Companies Act 2006 and have not been audited or reviewed by the Company's auditors. The information for the year ended 31 December 2014 has been extracted from the latest published financial statements which received an unqualified audit report and have been filed with the Registrar of Companies. No statutory accounts in respect of any period after 31 December 2014 have been reported on by the Company's auditors or delivered to the Registrar of Companies. The Half-Year Report is available at the Company's website address, www.fcpet.co.uk.

 

For more information, please contact:

 

Hamish Mair (Fund Manager)

0131 718 1184

hamish.mair@bmogam.com

Gordon Hay Smith (Company Secretary)

0131 718 1018

gordon.haysmith@bmogam.com

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGUCWRUPAGAM
Date   Source Headline
30th Jun 20223:22 pmRNSChange of Name
17th Jun 20224:07 pmRNSTransaction in Own Shares
15th Jun 20225:01 pmRNSTransaction in Own Shares
27th May 20229:08 amRNSResult of Annual Gen Meeting & Directorate Change
26th May 202212:02 pmRNS1st Quarter Results
27th Apr 202210:07 amRNSDirector/PDMR Shareholding
27th Apr 202210:06 amRNSDirector/PDMR Shareholding
27th Apr 202210:04 amRNSDirector/PDMR Shareholding
26th Apr 20223:24 pmRNSDirector/PDMR Shareholding
26th Apr 20223:23 pmRNSDirector/PDMR Shareholding
25th Apr 20229:24 amRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
1st Apr 202210:17 amRNSHolding(s) in Company
1st Apr 202210:09 amRNSHolding(s) in Company
30th Mar 20222:56 pmRNSDirector/PDMR Shareholding
30th Mar 20222:54 pmRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSAnnual Financial Report
17th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSUpdate on Secondary Placing
13th Jan 20227:00 amRNSProposed Secondary Placing
4th Jan 20227:00 amRNSInvestor Presentation
26th Nov 20217:00 amRNS3rd Quarter Results
22nd Nov 202110:47 amRNSHolding(s) in Company
15th Oct 20219:55 amRNSHolding(s) in Company
15th Oct 20217:00 amRNSKepler Trust Intelligence: New Research
27th Aug 20217:00 amRNSInterim results and Quarterly Dividend
25th Jun 20213:14 pmRNSHolding(s) in Company
27th May 20212:15 pmRNSAGM Statement
27th May 202111:51 amRNSQuarterly NAV and Dividend Announcement
29th Apr 20211:01 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSAnnual Financial Report
26th Mar 20217:00 amRNSFinal Results
24th Mar 20217:00 amRNSInvestment Update
8th Feb 20213:00 pmRNSHolding(s) in Company
9th Dec 20209:22 amRNSHolding(s) in Company
27th Nov 202010:52 amRNSHolding(s) in Company
25th Nov 20209:18 amRNSKepler Trust Intelligence: New Research
20th Nov 20207:00 amRNSQuarterly results and dividend announcement
15th Oct 20204:09 pmRNSNon-Executive Director Declaration
18th Sep 20202:09 pmRNSDirector/PDMR Shareholding
16th Sep 20202:24 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
1st Sep 202012:24 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSInterim Results
20th Jul 20207:00 amRNSNon-Executive Director Declaration
17th Jul 20207:00 amRNSAppointment of Corporate Broker
9th Jun 20209:57 amRNSHolding(s) in Company
4th Jun 20207:00 amRNSDirectorate Change
22nd May 20204:11 pmRNSHolding(s) in Company
21st May 20207:00 amRNSFirst Quarter Results and Dividend Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.